Scientific deep-dive

Capsaicin and Capsinoids for Weight Loss: Eight Measures, Eight Nulls

A dose-response meta-analysis of 13 randomized trials and 838 participants found no effect of capsinoids on body weight, BMI, waist circumference, fat mass, fat-free mass, waist-hip ratio, visceral fat or body fat percentage.

By Nora Bissett · Pricing Editor
Editorially reviewed & fact-checked against primary sources · How we verify contentLast reviewed
5 min read·1 citations

Capsinoids — the non-pungent relatives of the compound that makes chili hot — are sold on the theory that they raise energy expenditure. A systematic review and dose-response meta-analysis pooled 13 randomized trials and 838 participants and measured eight things: body weight, BMI, waist circumference, waist-hip ratio, fat mass, fat-free mass, visceral fat area and body fat percentage. None of them changed.[1]

The eight nulls

Capsinoid supplementation against control, 13 trials, 838 participants, 19 effect sizes.[1]
MeasureP value
Body weight0.230
Body mass index0.182
Waist circumference0.611
Waist-hip ratio0.599
Fat mass0.946
Fat-free mass0.917
Visceral fat area0.836
Percentage body fat0.973

Several of those p values sit close to 1, which is worth noticing. This is not a set of near-misses in an underpowered analysis; it is a set of results centered on no difference at all.

The subgroup that gets quoted

The same paper reports one positive finding: in trials conducted on overweight participants that lasted twelve weeks or longer, there was a significant and modest reduction in body weight. That sentence is the one you will meet on a product page, usually without the eight nulls it sits inside.[1]

The same paper undercuts its own subgroup. Its dose-response analysis found no significant non-linear association between capsinoid dosage and body weight, and none between study duration and body weight either. If longer really produced more effect, a duration relationship should appear in that analysis. It does not.

A subgroup finding inside an overall null result is a hypothesis, not a conclusion. Split any dataset enough ways and some slice will reach significance. That does not make it false — it makes it the thing you design the next trial to test, which is precisely what the authors ask for: well-designed randomized trials with larger samples and longer duration.

What about the brown fat studies?

Capsinoids have been shown to activate brown adipose tissue and to increase energy expenditure in laboratory conditions, and that is the mechanism the marketing rests on. It is a real mechanism. The meta-analysis above is what happened when the mechanism was tested against the outcome: eight measures of body composition, none of which moved.

An effect on energy expenditure that never shows up on the scale, the tape measure or a DXA scan is a finding about physiology, not about weight loss.

For where the evidence sits on other supplements sold for weight, our supplement evidence grader carries a graded entry with its primary study for sixteen of them. For what actually moves body composition during weight loss, see protein targets and the lab panel and bone density and exercise.

Frequently Asked Questions

A dose-response meta-analysis of 13 randomized trials with 838 participants found no significant effect of capsinoid supplementation on body weight, BMI, waist circumference, waist-hip ratio, fat mass, fat-free mass, visceral fat area or percentage body fat.
Capsinoids do activate brown adipose tissue and can increase energy expenditure under laboratory conditions. The meta-analysis is what happened when that mechanism was tested against actual body composition, and none of the eight measures moved.
A subgroup of trials in overweight participants lasting twelve weeks or more did show a modest significant reduction in body weight. It sits inside an overall null result, and the same paper's dose-response analysis found no significant relationship between duration and weight — which argues against the subgroup being a real duration effect.
The meta-analysis addressed efficacy rather than safety. Capsinoids are the non-pungent analogs of capsaicin and are generally consumed as food compounds, but supplement doses are a different matter from culinary ones and are not standardized.

References

  1. 1.Sheikhhossein F, Amini MR, Askari M, et al. The effects of capsinoids supplementation on body composition and anthropometric measures: A systematic review and dose-response meta-analysis of randomized controlled trials Clinical Nutrition ESPEN. 2022. PMID: 36513480.

Creatine on a GLP-1: The Trial Nobody Has Run

No completed trial has tested creatine in people taking a GLP‑1. The 2026 review of lean-mass preservation classes it as indirect evidence — and the lean-mass number most often quoted for it is one creatine inflates.

6 min read

GLP-1 Drugs and the Gut Microbiome: What 38 Studies Could Not Agree On

A systematic review of 38 studies found no single direction of effect. For semaglutide a beneficial bacterium rose while microbial diversity fell, and in the one randomized human study the bacterial shifts were not associated with glucose control at all.

6 min read

GLP-1s During Ramadan: What the Four Studies Actually Tested

Four studies exist on taking a GLP‑1 through Ramadan and all four enrolled people with type 2 diabetes. Both randomized trials compared against a sulfonylurea — a drug class whose defining hazard is low blood sugar.

7 min read

Gymnema Sylvestre: A Meta-Analysis With No Control Group

The meta-analysis behind gymnema's blood-sugar claim pooled 10 studies and 419 people and reported large effects at p < 0.0001 — calculated by comparing participants after treatment with the same participants at baseline, with heterogeneity up to 99%.

5 min read

Nutrition Drinks Alongside a GLP-1

A real-world study associated nutrition drinks with more fat loss and a better fat-to-lean ratio. The strongest effects were among people who complied — which is a compliance finding wearing a product's clothes.

5 min read

Plant-Based Protein on a GLP-1: What Closes the Gap, and Why the Drug Widens It

Across a full day at high protein intake a vegan diet matched an omnivorous one for muscle. Per meal it produced 47% less muscle protein synthesis — and a GLP-1 works against the intake that closes the gap.

7 min read

Where to get GLP-1 online, safely: sellers our editors have checked

These are telehealth sellers our editors have checked. For each one we hold a price, the form the drug comes in, and the states it reaches.

No insurance needed · vetted by our editors

Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more

6.7

Eden

Coverage in all 50 states, which most of the register will not confirm

8.3

SnagRx

Semaglutide at $99/month, 48% under the register median

7.7

Breeze Meds

Knowing which pharmacy fills the vial — it names Belmar Pharmacy